Nationwide genomic data analysis of central nervous system tumors in Japan based on C-CAT database
International Journal of Clinical Oncology · 2026-07 · 31 (7) · 1226-1235
DOI: 10.1007/s10147-026-03031-0 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Clinical Oncology, online erschienen am 06.05.2026. Verfasst von Daisuke Kawauchi und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurosurgery and Neuro-Oncology, National Cancer Center Hospital, 5-1-1 Tsukiji, Chuo-Ku, Tokyo, 104-0045, Japan. Hauptthemen laut MEDLINE: Central Nervous System Neoplasms. Die Arbeit nennt 13 Literaturangaben.
Abstract (Originalsprache)
Comprehensive genomic profiling test (CGPT) using next-generation sequencing (NGS) plays a vital role in cancer diagnosis, treatment option, and prognostic evaluation. In Japan, three tissue-based CGPTs, FoundationOne® CDx, GenMineTOP, and NCC OncoGuide™, are reimbursed under public health insurance. However, their comparative performance in central nervous system (CNS) tumors remains unclear. We conducted a nationwide, retrospective analysis using data from the Center for Cancer Genomics and Advanced Therapeutics database. A total of 1,151 patients with CNS tumors who underwent CGPT between August 2023 and April 2025 were included. Patient characteristics, genetic mutations, tumor mutation burden, and numbers of drug and clinical trial suggestions were compared across the three CGPTs. FoundationOne® CDx detected significantly more mutations and copy number alterations than GenMineTOP and NCC OncoGuide. It also proposed more off-label drugs and domestic clinical trials. Conversely, GenMineTOP demonstrated the highest detection rate of gene fusions (9.6%), including KIAA1549-BRAF, FGFR3-TACC3, and EGFR-SEPT14, and PTPRZ1-MET. Furthermore, GenMineTOP identified germline mutations in 4.6% of patients, commonly involving TP53, BRCA2, and MSH6. FoundationOne® CDx exhibits greater number of mutations, copy number alterations, and generating therapeutic suggestions, while GenMineTOP excels in identifying fusion genes and germline variants. These findings underscore that each CGPT possesses distinct analytical strengths, and the choice of platform may influence the genomic landscape and therapeutic opportunities identified in CNS tumor patients.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Neurosurgery and Neuro-Oncology, National Cancer Center Hospital, 5-1-1 Tsukiji, Chuo-Ku, Tokyo, 104-0045, Japan.
- Department of Neurosurgery, Tokai University Hospital, 143 Shimokasuya, Isehara-Shi, Kanagawa, 259-1193, Japan.
- Department of Experimental Therapeutics, National Cancer Center Hospital, 5-1-1 Tsukiji, Chuo-Ku, Tokyo, 104-0045, Japan.
- Department of Laboratory Medicine, National Cancer Center Hospital, 5-1-1 Tsukiji, Chuo-Ku, Tokyo, 104-0045, Japan.
- Department of Genetic Medicine and Services, National Cancer Center Hospital, 5-1-1 Tsukiji, Chuo-Ku, Tokyo, 104-0045, Japan.
- Division of Brain Tumor Translational Research, National Cancer Center Research Institute, 5-1-1 Tsukiji, Chuo-Ku, Tokyo, 104-0045, Japan.
Zitieren
APA
Kawauchi, D., Ohno, M., Takahashi, M., Koyama, T., Sunami, K., Hirata, M., Yanagisawa, S., Omura, T., Aoki, T., Fujii, G., Saito, K., Yamamoto, T., Suzuki, H., & Narita, Y. (2026). Nationwide genomic data analysis of central nervous system tumors in Japan based on C-CAT database. International Journal of Clinical Oncology, 31(7), 1226-1235. https://doi.org/10.1007/s10147-026-03031-0
Vancouver
Kawauchi D, Ohno M, Takahashi M, Koyama T, Sunami K, Hirata M, et al. Nationwide genomic data analysis of central nervous system tumors in Japan based on C-CAT database. International Journal of Clinical Oncology. 2026;31(7):1226-1235. doi:10.1007/s10147-026-03031-0
BibTeX
@article{Kawauchi2026,
author = {Kawauchi, Daisuke and Ohno, Makoto and Takahashi, Masamichi and Koyama, Takafumi and Sunami, Kuniko and Hirata, Makoto and Yanagisawa, Shunsuke and Omura, Takaki and Aoki, Takuma and Fujii, Genta and Saito, Koji and Yamamoto, Tetsuya and Suzuki, Hiromichi and Narita, Yoshitaka},
title = {Nationwide genomic data analysis of central nervous system tumors in Japan based on C-CAT database},
journal = {International Journal of Clinical Oncology},
year = {2026},
volume = {31},
number = {7},
pages = {1226--1235},
doi = {10.1007/s10147-026-03031-0}
}
EUVIMED